|
⚲
|
| Keyboard |
| Velan Capital LP
✚
|
|
|---|---|
| CIK # | 0001964355, 0001848809, 0001785731 |
| CIK | Period |
|---|---|
| 0001964355 0001848809 0001785731 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 32.5 | ||
| Proteon Therapeutics Inc | 14.8 | ||
| Evommune Inc | 10.3 | ||
| Maplight Therapeutics Inc | 10.0 | ||
| Oxygen Biotherapeutics Inc | 9.3 | ||
| Abivax Sa | 8.6 | ||
| AP Pharma Inc /DE/ | 7.0 | ||
| Immix Biopharma Inc | 6.7 | ||
| Esperion Therapeutics Inc | 4.7 | ||
| Stellar Biotechnologies Inc | 4.3 | ||
| Anteris Technologies Global Corp | 3.9 | ||
| InspireMD Inc | 3.4 | ||
| Xencor Inc | 3.0 | ||
| Cerecor Inc | 2.8 | ||
| Eupraxia Pharmaceuticals Inc | 2.5 | ||
| CytomX Therapeutics Inc | 2.5 | ||
| Amplitude Healthcare Acquisition Corp | 2.3 | ||
| FITS My Style Inc | 2.3 | ||
| Lyell Immunopharma Inc | 2.0 | ||
| Profound Medical Corp | 1.9 | ||
| Signal Genetics Inc | 1.8 | ||
| Inotek Pharmaceuticals Corp | 1.1 | ||
| Kazia Therapeutics Ltd | 1.0 | ||
| Nasus Pharma Ltd | 0.8 | ||
| Cellect Biotechnology Ltd | 0.6 | ||
| Arrowhead Research Corp | 0.4 | ||
| Protagonist Therapeutics Inc | 0.4 | ||
| OVID Therapeutics Inc | 0.4 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001785731] | |
| 4 | [0001785731] | |
| 13F-HR | [0001848809] | |
| 3 | [0001848809] | |
| 4 | [0001848809] | |
| SC 13D | [0001848809] | |
| SC 13G | [0001848809] | |
| 3 | [0001964355] | |
| 4 | [0001964355] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alimera Sciences Inc ALIM
Warrants · derivative
|
2024-09-16 | Disposed to issuer | 800,000 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2024-09-16 | Disposed to issuer | 9,429,808 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2024-09-16 | Disposed to issuer | 4,178,725 | ||
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2024-09-16 | Disposed to issuer | 50,000 | ||
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2024-09-16 | Disposed to issuer | 1,825 | ||
|
Amplitude Healthcare Acquisition Corp JSPR
Common Stock, par value $0.0001 per share
|
2024-02-08 | Buy | 350,000 | $12.95 | 4,532,500 |
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2023-10-02 | Grant | 50,000 | $0.00 | |
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 7,000 | ||
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 2,924,762 | $2.10 | 6,142,000 |
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 4,178,725 | $1.70 | 7,103,832 |
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-08-15 | Conversion | 4,845,392 | $1.70 | 8,237,166 |
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 6,000 | ||
|
Alimera Sciences Inc ALIM
Series B Convertible Preferred Stock · derivative
|
2023-08-15 | Conversion | 8,117 | ||
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-09 | Buy | 72,023 | $4.99 | 359,395 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-04 | Buy | 243,614 | $4.51 | 1,098,699 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-09-03 | Buy | 277,424 | $4.39 | 1,217,891 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-26 | Buy | 73,230 | $4.30 | 314,889 |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock, $0.0013 par value
|
2019-08-23 | Buy | 130,826 | $4.31 | 563,860 |